Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.56 |
| ▸ | CA9 | Q16790 | 2/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | JAK2 | O60674 | 1/20 | 0.50 |
| ▸ | HTR5A | P47898 | 2/20 | 0.42 |
| ▸ | NOS2 | P35228 | 1/20 | 0.41 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.40 |
| ▸ | PLAU | P00749 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 2/20 | 0.38 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.38 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.38 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.36 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.36 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dihydrophenanthridine SCHEMBL29791568 | 1.00 | CA12 (0.56) | CA12CA9ALOX15HSD17B10GAA | |
| SCHEMBL27425414 | 0.98 | CA12 (0.54) | CA12CA9ALOX15HSD17B10GAA | |
| Dihydrophenanthridine SCHEMBL28195877 | 0.88 | CA12 (0.50) | CA12CA9ALOX15HSD17B10GAA | |
| SCHEMBL19594919 | 0.85 | PARP1 (0.49) | CA12CA9ALOX15HSD17B10GAA | |
| SCHEMBL21602736 | 0.83 | ALOX15 (0.53) | CA12CA9ALOX15HSD17B10GAA | |
| SCHEMBL21665091 | 0.83 | CA12 (0.48) | CA12CA9ALOX15HSD17B10GAA | |
| SCHEMBL11474110 | 0.83 | CA12 (0.59) | CA12CA9ALOX15HSD17B10GAA | |
| SCHEMBL24591666 | 0.80 | CA12 (0.46) | CA12CA9ALOX15HSD17B10GAA | |
| SCHEMBL20854469 | 0.80 | METAP2 (0.53) | CA12CA9ALOX15HSD17B10GAA | |
| SCHEMBL17108096 | 0.80 | JAK2 (0.54) | CA12CA9ALOX15HSD17B10GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119708022-A | Boron-nitrogen-containing organic compound, application thereof and organic electroluminescent device | 北京鼎材科技有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119569758-A | Boron-nitrogen-containing organic compound, application thereof and organic electroluminescent device | 北京鼎材科技有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-109438349-A | 6- (alpha-cyano imines) base phenanthridines class compound and its synthetic method | 上海大学 | 2019-03-08 | — | — | CN | claimed |
| US-20140155591-A1 | ARYLAMINE COMPOUND AND ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2014-06-05 | — | — | US | claimed |
| US-6903118-B1 | Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides | KLINGE PHARMA GMBH (DE) | 2005-06-07 | — | — | US | claimed |
| JP-58074633-A | — | — | None | — | — | JP | disclosed |
| US-12448370-B2 | Heterocyclic compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2025-10-21 | — | — | US | disclosed |
| CN-119708022-A | Boron-nitrogen-containing organic compound, application thereof and organic electroluminescent device | 北京鼎材科技有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-119564683-A | Combined synergistic pharmaceutical composition for resisting mycobacterial infection | 首都医科大学附属北京胸科医院 | 2025-03-07 | — | — | CN | disclosed |
| CN-119569758-A | Boron-nitrogen-containing organic compound, application thereof and organic electroluminescent device | 北京鼎材科技有限公司 | 2025-03-07 | — | — | CN | disclosed |
| US-12215063-B2 | Method for preparing deuterated compound | LG CHEM, LTD. (KR) | 2025-02-04 | — | — | US | disclosed |
| US-20240343750-A1 | Metallocene Catalyst Compounds for Producing Polyolefins | EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY (US) | 2024-10-17 | — | — | US | disclosed |
| US-5512563-A | TREATING DISEASES CAUSED BY EXCESS RENAL REABSORPTION OF WATER | AMERICAN CYANAMID COMPANY (US) | 1996-04-30 | — | — | US | disclosed |
| EP-0702004-A2 | 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amid derivatives | CIBA-GEIGY AG (CH) | 1996-03-20 | — | — | EP | disclosed |
| EP-0655451-A1 | Tetracyclic condensed heterocyclic compounds for the treatment of senile dementia | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1995-05-31 | — | — | EP | disclosed |
| EP-0640592-A1 | N-acylated tricyclic azaheterorings useful as vasopressin antagonists | AMERICAN CYANAMID COMPANY (US) | 1995-03-01 | — | — | EP | disclosed |
| EP-0051284-B1 | NOVEL THIAPROSTAGLANDIN E1 DERIVATIVES, PROCESS FOR PRODUCTION THEREOF, AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS | TEIJIN LIMITED (JP) | 1985-01-09 | — | — | EP | disclosed |
| US-4466980-A | Thiaprostaglandin E1 derivatives, process for production thereof, and pharmaceutical use thereof | TEIJIN LIMITED (JP) | 1984-08-21 | — | — | US | disclosed |
| JP-S5874633-A | PREPARATION OF CARBOXYLIC ACID | TEIJIN LTD | 1983-05-06 | — | — | JP | disclosed |
| EP-0051284-A1 | Novel thiaprostaglandin E1 derivatives, process for production thereof, and pharmaceuticals containing these compounds | TEIJIN LIMITED (JP) | 1982-05-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12215063-B2 | Method for preparing deuterated compound | CYP2F1, CYP21A2, HSD11B2 | CA12 319/4885CA9 270/4885ALOX15 1995/4885 |
| US-20240343750-A1 | Metallocene Catalyst Compounds for Producing Polyolefins | MLX, TSNAX, TXLNA | CA12 2779/4885CA9 4319/4885ALOX15 966/4885 |
| US-12448370-B2 | Heterocyclic compound and organic light-emitting device comprising same | CCNT1, CCNA1, CYP1A1 | CA12 3342/4885CA9 4006/4885ALOX15 601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.